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INTRODUCTION
Brain  endothelial  cells  (BEC),  highly  specialized 
endothelial cells, are the main constituents of the 
blood-brain  barrier  (BBB).  Structural  specializa-
tions of BEC include highly organized tight junc-
tions,  the  absence  of  expression  of  MHC  II  mol-
ecules, and highly developed transport systems (Prat 
et al., 1999). Due to these characteristics, BEC have 
a  decisive  role  in  the  selection  of  substances  and 
cells transported in or out of the CNS. In connec-
tion with migration of cells to the CNS, BEC display 
various adhesive molecules on their surface, such as 
VCAM-1,  ICAM-1,  PECAM-1,  ICAM-2,  CCL19, 
and E and P selectin in physiological and patho-
logical conditions (Engelhardt and Ransohoff, 2005; 
Ranshoff  et  al.,  2003,  Gavins  et  al.,  2007),  which 
allow them to communicate directly with leukocytes 
involved  in  normal  immune  surveillance  or  with 
activated cells infiltrating the CNS. Activated T cells 
can cross the compact BBB, and if they recognize 
target  structure(s)  in  the  CNS,  as  a  consequence 
various soluble factors are released that cause BEC 
to  become  less  restrictive,  leading  to  increased 
lymphocyte trafficking across the BBB as an early 
event in inflammatory CNS diseases (Archambault 
et al., 2005; Becher et al., 2006). Besides controlling 
transport  of  leukocytes  across  the  BBB,  BEC  are 
also  able  to  influence  immune  functions  of  CNS 
resident cells and blood-borne cells through secre-
tion of different substances, including nitric oxide 
(NO), prostaglandins, and cytokines such as IL-6, 
IL-8, MCP, RANTES, TNF-α, IL-1, GM-CSF, IL-10, 
and endothelin-1 (Zhao et al., 2006; Konsman et al., 
2007; Matsumura and Kobayashi, 2004; Reyes et al., 
1999).
The  pro-inflammatory  T  cell  cytokines  IFN-γ 
and IL-17 are considered to be among major cul-
prits  in  the  CNS  inflammatory  disease  multiple 
sclerosis (MS) and its animal model, experimental 
autoimmune encephalomyelitis (EAE) (Segal, 2005; 
Wheeler and Owens, 2005). A pivotal Th1 cytokine, 
IFN-γ  activates macrophages and up-regulates pro-
duction of a variety of pro-inflammatory mediators 
such  as  IL-12,  IL-15,  TNF-α,  interferon-inducible 
protein-10, and inducible NO synthase (iNOS) in 
different cell types. It is known that IFN-γ–secreting 
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Th1 cells are present in the CNS before the onset of 
clinical symptoms and disappear during the remis-
sion phase of EAE (juedes et al., 2000; Renno et al., 
1995). They are also present in MS lesions (Traugott 
et  al.,  1983).  Treatment  with  IFN-γ  exacerbates 
MS (Panitch et al., 1987), and mice deficient in T-
bet – master regulator of Th1 differentiation – are 
resistant  to  EAE  (Nath  et  al.,  2006).  Moreover,  it 
has  recently  been  shown  that  IFN-γ  largely  con-
tributes  to  myelin  destruction  in  a  mouse  model 
of demyelination (Mana et al., 2006). Recent data 
indicate that the newly discovered Th17 population 
is the pathogenic population in EAE pathogenesis 
(Aggarwal et al., 2003; Langrish et al., 2005). It has 
been demonstrated that Th17 cells are characterized 
by the production of a distinct profile of effector 
cytokines, including IL-17 (IL-17A), IL-17F, TNF-α, 
and IL-6 (Langrish et al., 2005; Betteli et al., 2008). 
Moreover, IL-17 is important in the induction and 
maintenance of inflammation, as it can induce the 
production of other cytokines and chemokines from 
a variety of cell types and coordinate the recruitment 
of neutrophils and monocytes to the site of inflam-
mation  (Kolls  and  Linden,  2004).  It  was  shown 
that in MS patients, IL-17 mRNA and protein were 
increased  in  both  brain  lesions  and  mononuclear 
cells  isolated  from  blood  and  cerebrospinal  fluids 
(Lock et al., 2002; Matusevicius et al., 1999). Further, 
induction of  EAE is blocked in mice deficient in 
IL-23, which promotes the differentiation of IL-17–
producing cells (Cua et al., 2003); adoptive transfer 
of  autoantigen  specific  Th17  cells  induced  EAE 
(Langrish et al., 2005); and finally, the development 
of EAE was significantly suppressed in IL-17 knock-
out mice or mice treated with anti–IL-17 vaccine 
(Komiyama et al., 2006; Wraith, 2006).
In  light  of  the  intimate  relationship  between 
BEC and peripherally activated T lymphocytes and 
the importance of IFN-γ and IL-17 for the patho-
genesis of MS and EAE, our aim was to investigate 
if BEC can influence production of these cytokines 
in T lymphocytes. We report here that BEC potently 
modulate  IFN-γ  (but  not  IL-17)  gene  expression 
and secretion. This influence could be of potential 
importance for regulation of the auto-aggressive T 
cell response.
MATERIALS AND METHODS
Murine  brain  endothelial  cell  line  bEnd.3  was 
obtained from the American Type Culture Collection 
(ATTC, MD, USA). The cells were grown in HEPES-
buffered  RPMI-1640  medium  (Sigma,  Germany) 
containing 10% heat-inactivated fetal bovine serum 
(PAA  Chemicals,  Austria),  antibiotic/antimycotic, 
and 2 mM glutamine. Cells from 22 to 25 passages 
were used for all experiments. Cervical lymph nodes 
(LN) were isolated from BALB/c mice and mashed 
through steel net into the medium. The resulting cell 
suspension (LNC) was centrifuged and resuspended 
for final counting and use in experiments. Adequate 
measures were taken to minimize pain or discom-
fort of the animals. For the experiments with co-
cultivation,  bEnd.3  cells  (2x105/well)  were  seeded 
in 24-well plates (Sarsted, Germany) and incubated 
overnight.  Subsequently,  LNC  (4x106/well)  were 
added  to  cultures,  either  directly  onto  bEnd.3  or 
into tissue culture inserts (0.2 µM Anapore mem-
brane,  Nunc,  Denmark)  that  prevented  contact 
between these two cell populations. The cells were 
cultivated  for  6  or  24  h  under  standard  condi-
tions (5% CO2, 37oC) in the presence or absence 
of 2.5 µg/ml of concanavalin A (ConA, Pharmacia, 
Sweden). Afterwards, cell culture supernatants were 
collected  and  frozen  until  used  in  ELISA  (mouse 
IL-17,  IFN-γ,  and  IL-12  ELISA  DuoSets,  R&D 
Systems, MN, USA), and the pelleted cells were used 
for  total  RNA  isolation  and  subsequent  real  time 
(RT)-PCR. Ribonucleic acid was reverse transcribed 
using  random hexamer primers and MMLV reverse 
transcriptase (Fermentas, Lithuania). The RT-PCR 
procedure was performed in the ABI PRISM 7500 
Sequence  Detection  System  (Applied  Biosystems, 
CA, USA) using the TaqMan Universal PCR Master 
Mix  (Applied  Biosystems).  Thermocycler  condi-
tions comprised the initial step (50oC for 2 min and 
subsequent heating to 95oC for 10 min). This was 
followed by a two-step PCR program at 95oC for 
15 sec and 60oC for 60 sec for 40 cycles. The PCR 
primers  and  probes  used  were  as  follows: IFN-γ 
forward primer 5'-TGG CAT AGA TGT GGA AGA 
AAA GAG -3'; IFN-γ - reverse primer 5'-TGC AGG 
ATT TTC ATG TCA CCA T-3'; IFN-γ  probe FAM 
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AAG A-3’ TAMRA; IL-17 forward primer 5’-ATC 
AGG  ACG  CGC  AAA  CAT  G-3’;  IL-17  reverse 
primer 5’-TGA TCG CTG CTG CCT TCA C -3’; IL-
17 probe FAM 5’-CTT CAT CTG TGT CTC TGA 
TGC TGT TGC TGC-3’ TAMRA; β-actin forward 
primer 5’-GCT TCT TTG CAG CTC CTT CGT-3’; 
β-actin  reverse  primer  5'-CCA  GCG  CAG  CGA 
TAT CG-3'; and β-actin probe VIC 5'-CAC CCG 
CCA CCA GTT CGC CAT-3' TAMRA. Expression 
of IL-17 and that of IFN-γ were determined relative 
to  expression  of  β-actin.  Relative  gene  expression 
in cultures grown in a medium without additional 
treatment was adopted as the value of an arbitrary 
unit. The results are presented as means ± SD of 
values obtained in repeated experiments. Student’s 
t test was performed for statistical analysis of the 
differences observed. A p value less than 0.05 was 
considered significant.
Abbreviations: CNS – central nervous system; ConA 
– concanavalin A; EAE – experimental autoimmune 
encephalomyelitis; IFN – interferon; IL – interleu-
kin; LNC – lymph node cells; MHC – major histo-
compatibility complex; MS – multiple sclerosis; Th 
– helper T cells.
RESULTS
Inasmuch as interaction of BEC and T cells migrat-
ing  to  the  CNS  parenchyma  is  important  for  the 
initiation  of  inflammation  in  the  CNS,  we  exam-
ined  the  influence  of  bEnd.3  cells  on  IFN-γ  and 
IL-17  generation  in  T  cells.  Production  of  IFN-γ 
in LNC was markedly inhibited in the presence of 
bEnd.3 cells after 6 or 24 h of cultivation (Fig. 1). A 
stronger effect was observed if the contact between 
cells was inhibited by a tissue culture insert. On the 
other hand, IL-17 release from LNC was just weakly 
modified  in  the  presence  of  bEnd.3  (Fig.  1).  The 
observed effect on cytokine production was not a 
consequence of decline in the number of LNC in co-
cultivation, as was deduced from cell viability and 
cell number determination by MTT assay and try-
pan blue staining, respectively (data not shown). In 
order to explore if the observed influence of bEnd.3 
on cytokine secretion by LNC was realized through 
gene expression modulation, LNC from co-cultiva-
tions in the presence of tissue culture inserts were 
centrifuged, RNA from pelleted cells was isolated, 
and RT-PCR analysis was performed. To judge from 
cytokine secretion, mRNA expression of IFN-γ (but 
not  IL-17)  was  markedly  down-regulated  in  the 
presence of bEnd.3 cells after 6 or 24 h of cultivation 
(Fig. 2). Thus, the influence of b.End3 cells on pro-
duction of IFN-γ was most likely mediated through 
inhibition of its gene expression. Importantly, there 
was a marked difference in the influence of bEnd.3 
on IFN-γ and IL-17, as these cells strongly inhibited 
the former but had only a minor (if any) effect on 
the latter.
Having  in  mind  that  IL-12  is  a  well-known 
promoter of IFN-γ synthesis, we explored the influ-
ence of bEnd.3 cells on IL-12 production in order to 
find out if the observed inhibitory effect of bEnd.3 
cells on IFN-γ production and gene expression was 
achieved  through  inhibition  of  IL-12  production. 
Significant inhibition of IL-12 production in co-cul-
tivations was observed when the cells were separated 
with a tissue culture insert (Fig. 3). Interestingly, in 
the presence of direct cell-cell contact between these 
cells, there was no inhibition of IL-12 secretion. At 
the same time, bEnd.3 cells did not produce detect-
able amounts of IL-12 in our experiments. Almost 
the exact same results were obtained in co-cultures 
lasting for 6 and 24 h, thus clearly suggesting that 
there was a correlation between IFN-γ and IL-12 
secretion in the absence (but not in the presence) of 
direct contact between bEnd.3 cells and LNC.
DISCUSSION
This study attempted to clarify if BEC can affect pro-
duction of marker Th1 and Th17 cytokines, IFN-γ 
and IL-17, respectively. The bEnd.3 cells used in the 
investigation strongly reduced IFN-γ (but not IL-17) 
production in vitro, thus implying a cytokine-specif-
ic effect of brain endothelial cells on lymphocytes.
Although  there  are  numerous  data  describing 
the influence of T cells and their cytokines on brain 
endothelium, and the function of BBB in particular 
(Engelhardt and Ransohoff, 2005), investigations of 
the opposite process are not so abundant. Regarding 
IFN-γ, there is a paper that seems to contradict our 
work, as it reports that human BEC do not influ-M. MOMčILOVIć ET AL. 32
Fig. 1. Influence of bEnd.3 cells on IFN-γ and IL-17 production 
in ConA-stimulated LNC. Lymph node cells were cultivated 
alone or co-cultivated with bEnd.3 cells for 6 h (A) or 24 h (B) 
in the absence (medium) or presence of ConA (2.5 µg/ml) with 
(insert) or without (contact) a tissue culture insert. Cell-free 
culture supernatants were subsequently collected and analyzed 
for the concentration of IL-17 and IFN-γ by ELISA. Data ob-
tained from 3-7 experiments are presented as means ± SD of 
values obtained in individual experiments. *p<0.05 represents 
statistical significance of the difference in relation to cultures of 
LNC cultivated alone and stimulated with ConA.
Fig. 2. Influence of bEnd.3 cells on IFN-γ and IL-17 gene ex-
pression in ConA-stimulated LNC. Lymph node cells (2x105/
well) were cultivated with or without ConA (2.5 µg/ml) in the 
absence or presence of bEND.3. In co-cultivations, bEND and 
LNC were separated by tissue-culture inserts. After 6 h (A, B) 
and 24 h (C, D) of cultivation, RNA was isolated, and reverse 
transcription followed by RT- PCR analysis for IFN-γ (A, C) 
and IL-17 (B, D) was performed. Data obtained from two ex-
periments are presented as means ± SD of values obtained in 
individual experiments. *p<0.05 represents statistical signifi-
cance of the difference in relation to cultures of LNC cultivated 
alone and stimulated with ConA.
Fig. 3. Influence of bEnd.3 cells on IL-12 production in ConA-stimulated LNC. Lymph node cells were culti-
vated alone or co-cultivated with bEnd.3 cells for 6 h (A) or 24 h (B) in the absence (medium) or presence of 
ConA (2.5 µg/ml) with (insert) or without (contact) a tissue culture insert. Cell-free culture supernatants were 
subsequently collected and analyzed for the concentration of IL-12. Data obtained from 3-5 experiments are 
presented as means ± SD of values obtained in individual experiments. *p<0.05 represents statistical significance 
of the difference in relation to cultures of LNC cultivated alone and stimulated with ConA.modulation of intERfERon-γ and intERlEuKin-17 PRoduCtion 33
ence IFN-γ production in Th1 cells (Biernacki et al., 
2001). However, differences in the species, purity of 
lymphocytes used, and stimulation employed in the 
two studies could easily account for the discrepancy 
in data. In their study, Biernacki et al. (2001) puri-
fied Th1 cells from peripheral blood of healthy sub-
jects and stimulated them with myelin basic protein 
(MBP). The obvious advantages of their system are 
purity of the used populations and antigen specific-
ity of the T cell response. On the other hand, using 
a mixed population isolated from lymph nodes and 
stimulation with a polyclonal T cell activator (ConA) 
more  clearly  elucidates  the  composition  of  cells 
infiltrating  CNS  and  the  inflammatory  milieu  in 
later phases of the autoimmune process in the CNS. 
Whatever  the  case,  here  we  record  a  pronounced 
effect  of  BEC  on  IFN-γ  production.  Interestingly, 
the reduction in IFN-γ correlated with reduction of 
IL-12 only in the event that bEnd.3 cells and LNC 
were separated by tissue culture inserts. It is pos-
sible that regulation of IL-12 production is exerted 
both by cell-cell contact and by soluble products, 
the  former  being  largely  positive  and  capable  of 
attenuating the inhibitory effects of soluble factors. 
In the absence of these stimulatory cellular interac-
tions, IL-12–producing cells remain exposed only to 
soluble factors and the net effect is inhibition of IL-
12 production. It therefore seems that down-regula-
tion  of  IL-12  production  in  co-cultivations  could 
be responsible for the effect on IFN-γ, but only if 
bEnd.3 and LNC are not in direct cell-cell contact. 
In direct contact with LNC, bEnd.3 do not inhibit 
IL-12 production and have a weaker effect on IFN-γ 
generation. There are many other cytokines that are 
important for IFN-γ regulation, and bEnd.3 could 
affect their production as well. Inasmuch as IL-12 
can be just one of the essential factors for IFN-γ 
synthesis, if IL-12 is inhibited there is inhibition of 
IFN-γ as well, but if IL-12 is not inhibited there is 
still room for IL-12–independent regulation of IFN-
γ production to take place. This difference in the 
effect regarding contact between bEnd.3 and LNC 
could be of importance for understanding data indi-
cating that Th1 cells (as major producers of IFN-γ) 
have the ability to migrate across the BBB (Biernacki 
et al., 2001; Prat et al., 2002), but that their encepha-
litogenic potential is weak in comparison to Th17 
cells.  Since  transmigration  is  a  complex  process 
involving at least two crucial steps: 1. entrance into 
perivascular spaces, and 2. passage to CNS paren-
chyma  (Bechmann  et  al.,  2007),  it  could  be  that 
BEC in direct contact during the first step weakly 
influence IFN-γ production of transmigrating Th1 
cells  and  allow  their  entrance  into  perivascular 
spaces, although already reducing their functional-
ity. In the second step, BEC acting through soluble 
factors  might  reduce  IFN-γ  production  and  Th1 
functionality (including encephalitogenicity) more 
aggressively. If we suppose that production of IFN-γ 
is a clear marker of Th1 functionality, the suggested 
speculation is even more attractive.
On  the  other  hand,  bEnd.3  had  a  limited  (if 
any) effect on IL-17 generation in LNC. It therefore 
seems  reasonable  to  assume  that  Th17  cells  pass 
the BBB with no major effect on their functionality. 
Thus, this result is in accordance with the presumed 
importance  of  Th17  cells  for  CNS  autoimmunity. 
There are plentiful data indicating a high encepha-
litogenic  potential  of  Th17.  A  pivotal  pathogenic 
role  for  IL-17  in  the  CNS  autoimmune  response 
is substantiated by attenuation of EAE with IL-17 
neutralization by anti–IL-17 antibodies or in mice 
genetically deficient in IL-17 or the IL-17 receptor 
(IL-17R) (Weaver et al., 2007; Betteli et al., 2008; 
Kramer and Gafen, 2007). First indications about 
the importance of Th17 cells for the pathogenesis of 
MS were significant increase in IL-17 gene expres-
sion  and  elevation  in  the  number  of  IL-17–pro-
ducing  CD4+  and  CD8+  T  cells  in  active  lesions 
in comparison with silent lesions or normal tissue 
(Lock et al., 2002; Tzartzos et al., 2008). Importantly, 
it  has  recently  been  reported  that  human  blood-
brain barrier (BBB) endothelial cells in MS lesions 
express receptors for IL-17, and that IL-17 disrupts 
BBB tight junctions both in vitro and in vivo (Kebir 
et al., 2007). It has also been shown that Th17 lym-
phocytes transmigrate efficiently across BBB endo-
thelial cells, highly express granzyme B, kill human 
neurons, and promote CNS inflammation through 
CD4+ lymphocyte recruitment (Kebir et al., 2007). 
Taken  together,  these  recent  data  clearly  suggest 
the importance of Th17 for the pathogenesis of MS. 
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perivascular  myeloid  CNS  dendritic  cells  arise  as 
a  consequence  of  migration  of  monocytes  across 
the human BBB through the concerted actions of 
BBB-secreted transforming growth factor-beta and 
granulocyte-macrophage  colony-stimulating  factor 
(Ifergan et al., 2008). Thus, there is the possibility 
that  BEC  even  promote  Th17  propagation  within 
the CNS.
Our results clearly suggest the ability of BEC to 
inhibit  IFN-γ  and  inability  to  interfere  efficiently 
with IL-17 production in activated T cells in vitro. 
Such a finding is important for understanding the 
different encephalitogen potentials of Th1 and Th17 
cells.  Furthermore,  it  contributes  to  the  growing 
body of data that should allow for the creation of 
more efficient therapy of neuro-inflammatory dis-
orders.
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Ћеﾭлиﾭјеﾭ моﾭждаﾭноﾭг еﾭндоﾭтеﾭлаﾭ су оﾭсноﾭвﾭниﾭ еﾭлеﾭмеﾭн­
тиﾭ  граﾭђеﾭ  крвﾭноﾭ­моﾭждаﾭнеﾭ  баﾭриﾭјеﾭреﾭ,  структуреﾭ  коﾭјаﾭ 
коﾭнтроﾭлиﾭшеﾭ улаﾭзаﾭк ћеﾭлиﾭјаﾭ иﾭмунскоﾭг сиﾭстеﾭмаﾭ у паﾭреﾭн­
хиﾭм CNS. Наﾭш циﾭљ јеﾭ биﾭоﾭ даﾭ сеﾭ иﾭспиﾭтаﾭ утиﾭцаﾭј оﾭвﾭиﾭх 
ћеﾭлиﾭјаﾭ наﾭ проﾭдукциﾭју иﾭнтеﾭрфеﾭроﾭнаﾭ­гаﾭмаﾭ иﾭ иﾭнтеﾭрлеﾭу­
киﾭнаﾭ­17, каﾭоﾭ кључﾭниﾭх проﾭиﾭнфлаﾭмаﾭтоﾭрниﾭх циﾭтоﾭкиﾭнаﾭ 
у неﾭуроﾭиﾭнфлаﾭмаﾭциﾭјиﾭ. Збоﾭг тоﾭгаﾭ смоﾭ вﾭршиﾭлиﾭ коﾭ­кул­
тиﾭвﾭаﾭциﾭју bEnd.3 лиﾭниﾭјеﾭ моﾭждаﾭноﾭг еﾭндоﾭтеﾭлаﾭ иﾭ ћеﾭлиﾭ­
јаﾭ лиﾭмфноﾭг чﾭвﾭоﾭраﾭ, иﾭ тоﾭ у приﾭсуствﾭу иﾭлиﾭ оﾭдсуствﾭу 
диﾭреﾭктноﾭг коﾭнтаﾭктаﾭ меﾭћу наﾭвﾭеﾭдеﾭниﾭм поﾭпулаﾭциﾭјаﾭмаﾭ, 
иﾭ оﾭдреﾭђиﾭвﾭаﾭлиﾭ еﾭкспреﾭсиﾭју геﾭнаﾭ иﾭ проﾭдукциﾭју наﾭвﾭеﾭдеﾭ­
ниﾭх циﾭтоﾭкиﾭнаﾭ. Поﾭкаﾭзаﾭлоﾭ сеﾭ даﾭ bEnd.3 ћеﾭлиﾭјеﾭ поﾭтеﾭнт­
ноﾭ иﾭнхиﾭбиﾭраﾭју проﾭдукциﾭју иﾭнтeрфеﾭроﾭнаﾭ­гаﾭмаﾭ, аﾭлиﾭ 
неﾭ иﾭ иﾭнтеﾭрлеﾭукиﾭнаﾭ­17. Таﾭкоﾭђеﾭ, меﾭриﾭлиﾭ смоﾭ иﾭ проﾭдук­M. MOMčILOVIć ET AL. 36
циﾭју иﾭнтеﾭрлеﾭукиﾭнаﾭ­12, глаﾭвﾭноﾭг стиﾭмулаﾭтоﾭрноﾭг циﾭтоﾭ­
киﾭнаﾭ заﾭ проﾭдукциﾭју иﾭнтеﾭрфеﾭроﾭнаﾭ­гаﾭмаﾭ, иﾭ поﾭкаﾭзаﾭлиﾭ 
даﾭ јеﾭ иﾭ њеﾭгоﾭвﾭаﾭ проﾭдукциﾭјаﾭ смаﾭњеﾭнаﾭ у коﾭ­култиﾭвﾭаﾭциﾭјиﾭ 
bEnd.3  ћеﾭлиﾭјаﾭ  иﾭ  ћеﾭлиﾭјаﾭ  лиﾭмфноﾭг  чﾭвﾭоﾭраﾭ.  Заﾭпаﾭжеﾭнаﾭ 
раﾭзлиﾭчﾭиﾭтоﾭст у деﾭлоﾭвﾭаﾭњу ћеﾭлиﾭјаﾭ моﾭждаﾭноﾭг еﾭндоﾭтеﾭлаﾭ 
наﾭ двﾭаﾭ оﾭсноﾭвﾭнаﾭ проﾭиﾭнфлаﾭмаﾭтоﾭрнаﾭ циﾭтоﾭкиﾭнаﾭ јеﾭ оﾭд знаﾭ­
чﾭаﾭјаﾭ заﾭ раﾭзумеﾭвﾭаﾭњеﾭ коﾭмплеﾭксноﾭг проﾭцеﾭсаﾭ реﾭгулаﾭциﾭјеﾭ 
иﾭнфлаﾭмаﾭциﾭјеﾭ у CNS.